ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 279503 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 279503; 2) Community: the network communities that were significantly associated with the response to NSC 279503; 3) Molecule: the relationships between components within communities and NSC 279503; 4) MDR: the compounds that were significantly associated with the NSC 279503.

NSC Compound Enrichment Correlation
NSC 104801 Cytembena 0.024108502230778 0.24114994
NSC 113423 NSC 113423 0.024108502230778 0.38831639
NSC 132791 Butyric acid, 2-hydroxy-2-methyl-, 4-ester with 1,3a.beta.,4,7,7a.alpha.,11,11a,11b.alpha.-octahydro-1.alpha.,2.alpha.,4.beta.,11.beta.-tetrahydroxy-3.alpha.,8,11a.beta.-trimethyl-2H-1,11c.beta.-(epo 0.024108502230778 0.61268921
NSC 133118 2H-1,2,3-Triazolo[4,5-d]pyrimidin-7-amine, 2-.beta.-D-ribofuranosyl- (9CI) 0.024108502230778 -0.0077967894
NSC 13484 Null 0.024108502230778 0.25074214
NSC 252628 1H-Purine, 6-[(1-methyl-4-nitro-1H-imidazol-5-yl)seleno]- 0.024108502230778 0.030307018
NSC 326061 1-Piperidinecarbothioic acid, 2-ethyl-, [1-(2-pyridinyl)ethylidine]hydrazide 0.0241085022307781 0.038560677
NSC 330507 Tanespimycin 0.0241085022307781 0.24375036
NSC 58574 Pyrimidine, 2,4,5-trichloro-6-propyl- 0.0241085022307781 0.076513098
NSC 623084 Null 0.0241085022307781 0.096175336
Total:146  Current:82    [First] [Prev] [Next] [Last]